2024 International Congress Archives - Page 79 of 181

Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies

I. Rektorova, Z. Zeleznikova, L. Brabenec, K. Mitterova, L. Novakova (Brno, Czech Republic)
Early Dementia with Lewy Bodies and Parkinson’s Disease with RBD: two faces of the same coin?

B. Orso, P. Mattioli, F. Famà, F. Massa, M. Pardini, A. Brugnolo, N. Girtler, S. Raffa, L. Sofia, S. Morbelli, D. Arnaldi (Genoa, Italy)
Early GBA-Related Parkinson’s Disease has a Distinct Clinical Phenotype and Cholinergic Innervation

S. Slingerland, S. Zee, G. Carli, A. Slomp, E. D'Angremont, J. Boertien, T. Laar (Groningen, Netherlands)
Early Outcomes Support use of a Remote Cross-Border Surgical Centre for Deep Brain Stimulation in Parkinson’s Disease

E. Donlon, S. Abdullah, F. Ronan, M. Garvey, N. Austin, E. Reynolds, F. Ruggieri, T. Lynch, C. Fearon, C. Moran, E. Pereira, R. Walsh (Dublin, Ireland)
Early Syndromes and Clinicopathologic Progression in Progressive Supranuclear Palsy

D. Ono, H. Sekiya, N. Ghayal, A. Maier, S. Roemer, D. Dickson (Jacksonville, USA)
Early-onset Parkinsonism as Presenting Manifestation of CADASIL in a Mexican Woman with NOTCH3 c.1732C>T Pathogenic Variant

M. Arbeu Reyes, B. Madariaga Cortés, S. Castillo Torres (Puebla, Mexico)
ECAP-Controlled Closed-Loop SCS Alleviates Neuropathic Pain and Improves Motor Function in a Patient Suffering from Parkinson’s Disease and Radicular Pain

Z. Zamfirov, D. Mugan, G. Ahluwalia (Annapolis, USA)
Ecopipam does not adversely affect Metabolic Parameters in Pediatric Subjects with Tourette Syndrome: Results from a Phase 2b with 12-month Open Label Extension Study

D. Gilbert, S. Atkinson, G. Karkanias, F. Munschauer, S. Wanaski, T. Cunniff (Cincinnati, USA)
Education Levels on Diagnostic Delay Phase and Initial Symptom Perception Among Hispanic Patients with Parkinson’s Disease: A Cross-Sectional Study

C. Rodriguez-Alarcon, D. Piana-Castillo, G. Faggioni-Sanchez, D. Bustamante-Mieles, M. Barreiro-Guillén, C. Cevallos-Velasco, R. Santibanez-Vasquez (Guayaquil, Ecuador)
Educational Programs for Patients with Parkinson disease and Deep Brain Stimulation: Scoping Riview

M. Petralito, C. Tedesco, F. Fanari, G. Pucciarelli, R. Caruso (Roma, Italy)
EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases.

R. Heo, J. Wallner, N. Mukhopadhyay, D. Krusienski, M. Barrett (Richmond, USA)
EEG Profiles in People with Functional Movement Disorders Before and After a Single Bout of Hatha Yoga and Moderate-vigorous Intensity Aerobic Exercise: A Protocol for a Pilot Feasibility Study

D. Kipnis, P. Smith, S. Leung, M. Bjalme-Evan, A. Nesru, C. Amlang, H. Shah, K. Froud, L. Quinn (New York, USA)
Effect of bilateral internal segment of the globus pallidus deep brain stimulation on acquired multifocal dystonia due to natural gas intoxication.

A. Luque-Ambrosiani, D. Macías-García, F. Carrillo, L. Muñoz-Delgado, S. Jesús, A. Adarmes-Gómez, E. Ojeda-Lepe, Y. Chocrón-González, M. Oliver-Romero, P. Mir (Seville, Spain)
Effect Of Botulinum Toxin On Non-Motor Symptoms In Adult-Onset Idiopathic Focal Dystonia

S. Mehta, R. Gupta, N. Balaini, S. Grover, V. Lal (Chandigarh, India)
Effect of Diabetes Mellitus on the Phenotype of Parkinson’s Disease

IH. Kwak, HI. Ma, YE. Kim, JJ. Lee (Anyang-si, Republic of Korea)
Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results from a Phase IIb Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome

D. Gilbert, G. Karkanias, S. Atkinson, F. Munschauer, S. Wanaski, T. Cunniff (Cincinnati, USA)
Effect of Istradefylline on Motor and Non-motor Symptoms in Patients with Parkinson’s Disease: the ISTRA ADJUST PD Randomized, Controlled Study

H. Nagayama, T. Hatano, R. Sengoku, N. Yanagisawa, O. Kano (Tokyo, Japan)
Effect of Levodopa therapy in Hypokinetic Dysarthria in Parkinson’s Disease

E. Smaoui, N. Farhat, S. Daoud, K. Moalla, N. Bouattour, M. Damak, C. Mhiri (Sfax, Tunisia)
Effect of Opicapone and Levodopa on Daily Motor Patterns in Parkinson’s Disease Patients with Early Motor Fluctuations: Findings from the Korean ADOPTION Study

J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)
Effect of Opicapone and Levodopa on the Different Daily OFF Patterns in Patients with Parkinson’s Disease and Early Motor Fluctuations: Findings from the Korean ADOPTION Study

J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)
Effect of Orthostatic Hypotension Medications on Orthostatic Ratio: A Systemic Review and Meta-Analysis

V. Pham, M. Rashid, B. Kung, S. Hossain (Toledo, USA)
Effect of Prasinezumab on Parkinson’s Disease Motor Progression in a Long-term Open-label Extension of the PASADENA Trial

G. Pagano, A. Monnet, A. Reyes, B. Ribba, H. Svoboda, T. Kustermann, T. Simuni, R. Postuma, N. Pavese, F. Stocchi, K. Brockmann, K. Smigorski, V. Gerbaldo, P. Fontoura, R. Doody, G. Kerchner, P. Brundin, K. Marek, A. Bonni, T. Nikolcheva (Basel, Switzerland)
Effect of rehabilitation therapy on the motor functions in patients with multiple system atrophy

J. Lee, S. Jo, M. Choi, SJ. Chung (Seoul, Republic of Korea)
Effect of Tactile Cueing on Dual Task Performance in Parkinson’s Disease-A Systematic Review and Meta-Analysis

V. Azoidou, A J. Noyce, C. Simonet (London, United Kingdom)
Effect of Target Selection on Mood, Pain, and Medications after DBS in PD

J. Jiao, B. Brumbach, Y. Lin, A. Ko, D. Safarpour (Palo Alto, USA)
Effect of the mGlu2 positive allosteric modulator biphenyl-indanone A on parkinsonian disability in the 6-hydroxydopamine-lesioned rat

W. Kang, Y. Kulkarni, I. Frouni, C. Kwan, D. Bédard, P. Huot (Montreal, Canada)
Effect of various mGlu2 and mGlu2/3 activators on parkinsonism: a sub-analysis in the MPTP-lesioned primate

W. Kang, I. Frouni, S. Nuara, C. Kwan, J. Gourdon, D. Bédard, P. Huot (Montreal, Canada)
Effect on Cognition and Affect in Patients with Deep Brain Stimulation for Parkinson’s Disease from Low Socioeconomic Status

D. Nguyen, R. Parihar, J. Shen, N. Baxi (Bronx, USA)
Effective Management of Generalized Dystonia with Unilateral Deep Brain Stimulation – Killing Two Birds with One Stone?

K. Massruha, I. Brum, C. Listik, J. Yamamoto, S. Casagrande, M. Belo Silva, P. Medeiros Lacerda, V. Zanesi Maciel, R. Cury, E. Barbosa (São Paulo, Brazil)
Effectiveness of abobotulinumtoxinA in adults with lower limb spasticity: Results from the AboLiSh real world observational study

A. Esquenazi, R. Zorowitz, S. Ashford, M. Beneteau, P. Maisonobe, C. Hannes, J. Jacinto (Elkins Park, USA)
Effectiveness of Deutetrabenazine for Tardive Dyskinesia When Initiated Using a 4-Week Patient Titration Kit: Final Results of the START Study

K. Anderson, M. Konings, S. Finkbeiner, J. Bennett, M. Asim Nisar, G. Alva, A. Cutler (Washington, USA)
Effectiveness of Lead-Point in Parkinson`s Model of STN-MER with DBS: A Study of Predicting Motor progression

V. Rama Raju (Hyderabad, India)
Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Activities of Daily Living, Behavioural and Cognitive ability (A-B-C) of PD Patients: A Randomized Controlled Trial

R. Makkar, R. Hazrati, A. Nehra (Ghaziabad, India)
Effectiveness of Subthalamic nucleus (STN) Deep Brain Stimulation Surgery (DBS) in patients with Parkinson’s Disease: A Patient and Caregiver reported outcome

S. Majumdar, S. Shee, S. Choudhury, J. Ganguly, P. Basu, N. Pandita, H. Kumar (Kolkata, India)
Effectiveness of VIM DBS for Head Tremor in Essential Tremor Patients: A Single-center Experience

M. Munyeshyaka, C. Piccinin, M. Medina-Pizarro, H. Fernandez, S. Saar (Cleveland, USA)
Effects of ATH434, a Clinical-Phase Small Molecule with Moderate Affinity for Iron, in a Parkinson’s Disease Model in Macaques

M. Bradbury, M. Aumann, D. Claassen, D. Finkelstein (Newark, USA)
Effects of ectopic dopamine D2 autoregulation of raphe-striatal projecting neurons on established L-DOPA-mediated behaviors in a hemiparkinsonian rat model

A. Centner, N. Lipari, C. Budrow, G. Mcmanus, I. Sandoval, K. Tseng, F. Manfredsson, C. Bishop (Binghamton, USA)
Effects of GBA mutations in patients with Parkinson’s disease and Levodopa-carbidopa intestinal gel: a nation-wide longitudinal multicentre ‘real-world’ study.

R. Cilia, F. Colucci, E. Cereda, V. Leta, M. Zibetti, M. Carecchio, S. Bonvegna, G. Calandra-Buonaura, R. Cerroni, R. de Micco, S. Tamburin, L. Magistrelli, F. Lena, M. Mascia, M. Picillo, G. Cossu, M. Marano, C. Leuzzi, C. Comi, A. Zampogna, C. Pellicano, S. Barca, V. Fioravanti, A. Pilotto, R. Zangaglia, M. Avenali, C. Sorbera, F. Di Biasio, F. Arienti, A. Nicoletti, C. Bagella, MC. Malaguti, A. Ranghetti, E. Caputo, D. Alimonti, E. Torre, GD. Oggioni, AE. Elia, N. Golfrè Andreasi, G. Devigili, B. Garavaglia, G. Imbalzano, T. Schirinzi, F. Cavallieri, A. Priori, M. Sessa, F. Tamma, M. Canesi, P. Solla, M. Zappia, A. Di Fonzo, L. Avanzino, A. Quartarone, EM. Valente, C. Pacchetti, A. Padovani, F. Valzania, A. Suppa, MT. Pellecchia, N. Modugno, M. Tinazzi, A. Tessitore, A. Stefani, P. Cortelli, IU. Isaias, A. Antonini, MC. Sensi, L. Lopiano, R. Eleopra (Milan, Italy)
Effects of Loading, Tapping Performance, and Ballistic Movements on Postural Tremor Features in Patients with Essential Tremor

D. Birreci, D. Costa, L. Angelini, A. Cannavacciuolo, M. Passaretti, A. Martini, M. de Riggi, G. Paparella, M. Bologna (Rome, Italy)
Effects of Mental Practice on FOG in People with Parkinson’s Disease: a Randomized Clinical Trial

P. Silva, K. Honda, I. Nascimento, K. Nobrega, N. Pereira, T. Barolli (Sao Paulo, Brazil)
Effects of Osteopathic Manipulative Treatment (OMT) on Lower Extremity Muscle Characteristics in Parkinson’s Disease (PD) Patients

R. Radigan, A. Finkelstein, M. Mehra, P. Bhushan, T. Lombardo, S. Yao (Old Westbury, USA)
Effects of Sample Collection Methods on Skin Sebum Volatilome Composition in Parkinson’s Disease Patients – a Methodological Pilot Study

V. van Midden, L. Strojnik, M. Mencin, N. Ogrinc, M. Kojović (Ljubljana, Slovenia)
Effects of striatal dopamine depletion and altered brain metabolism on Parkinson’s disease

HS. Yoo, PH. Lee, CH. Lyoo (Seoul, Republic of Korea)
Effects of Telerehabilitation on Balance, Gait, Functional Mobility, Physical Activity, Quality of Life, and Social Support Among Adults with Parkinson Disease: A Systematic Review

P. Darbandsari, L. Pescatello, D. Piscitelli, J. Smith, C. Colon-Semenza (Storrs, USA)
Effects of Transpinal Magnetic Stimulation (TsMS) in Patients Diagnosed with Spinocerebellar Ataxia 3 (SCA 3)

K. Silveira Massruha, R. Bernhart Carra, J. Simões, G. Nunes Simões, J. Reis Menezes, V. Zanesi Maciel, M. Belo Silva, P. Medeiros Lacerda, T. Gonçalves Guimarães, E. Reis Barbosa, R. Gisbert Cury (São Paulo, Brazil)
Effects on Speech After the Use of Swallow Against Resistance Exercise Device in Parkinson’s Disease Patients

R. Lee, H. Hassan, E. Jackowiak, R. Brennan, M. Kern, R. Shaker (Milwaukee, USA)
Efficacy and Safety of Amantadine in Parkinson’s Disease with Dyskinesia and Motor Fluctuations: A Systematic Review and Meta-Analysis

S. Rujirussawarawong, S. Aungsumart, C. Kasemsuk, N. Limotai (Bangkok, Thailand)
Efficacy and Safety of Controlled-Release Levodopa in Parkinson’s Disease: a Systematic Review and Meta-Analysis

G. Bolner, Y. Rossi, E. de Almeida, F. de Oliveira, V. Müller, L. Barbosa Lima, A. Rossato, G. Guindani Maia, A. Hilbig (Porto Alegre, Brazil)
Efficacy and Safety of DaxibotulinumtoxinA-lanm for Injection in Adults with Cervical Dystonia: Pooled Global Analysis of ASPEN-1 and ASPEN-1-CN

D. Truong, H. Xingyue, A. Ellenbogen, J. Lingjing, K. Dashtipour, A. Patel, T. Gross, R. Kazerooni, C. Gallagher, F. Xiaojin, S. Yunan, G. Lei, W. Xinhua, D. Hollander (Riverside, USA)
Efficacy and Safety of Foslevodopa/Foscarbidopa in People With Parkinson’s Disease With and Without Care Partner Support

M. Soileau, J. Bronstein, L. Harmer, M. Shah, R. Gupta, L. Verhagen Metman (Georgetown, USA)
Efficacy of Audiovisual Neuromodulation in the Treatment of Parkinson’s Disease

O. Alenikova, L. Parkhach, E. Bоsiakova, G. Zobnina (Minsk, Belarus)
Efficacy of Continuous Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor Signs of PD and Experiences of Daily Living

O. Rascol, S. Isaacson, P. Lewitt, W. Poewe, J. Ferreira, N. Lopes, S. Sopromadze, J. Pereira, C. Olanow (Toulouse, France)
Efficacy of Novel A2A/A1 Antagonist in Motor and non-Motor Symptoms of MPTP-Treated Macaques

J. Jung, Y. Lee, Y. Kim (Hwaseong-si, Gyeonggi-do, Republic of Korea)
Efficacy of Opicapone and Levodopa with Different Levodopa Daily Doses in Parkinson’s Disease Patients with Early Motor Fluctuations: Findings from the Korean ADOPTION Study

J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)
Efficacy Remaining at Time of Requested Retreatment Following Botulinum Toxin Treatment for Cervical Dystonia: Potential for a New Treatment Paradigm with DaxibotulinumtoxinA

A. Ellenbogen, R. Hauser, A. Patel, P. Mcallister, D. Vitarella, T. Gross, R. Kazerooni, C. Gallagher, D. Hollander (Farmington Hills, USA)
Efficiency of AI-Based Service for Screening Diagnostics of Parkinson’s Disease (Brainphone Project)

D. Khasanova, I. Khasanov, Z. Zalyalova (Kazan, Russian Federation)
eHealth – an Opportunity for personalized Care? – Healthcare Professionals’ Technology Acceptance in the Care of Parkinson’s Patients

J. Stuempel, J. Hohn, V. Fleckenstein, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)
eHealth Technologies for People with Parkinson’s: Acceptance & Implications

J. Stuempel, V. Fleckenstein, J. Hohn, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)
Ektacytometry in Neuroacanthocytosis

M. Paucar, C. Rubin, J. Wincent, S. Hertegård, R. Möller, S. Beshara, P. Svenningsson (Stockholm, Sweden)
Electrophysiological study of 122 Tunisian patients with autosomal recessive cerebellar ataxia

L. Hlioui, R. Zouari, R. Amouri, MZ. Saied, D. Ben Mohamed, A. Rachdi, S. Ben Sassi (Tunis, Tunisia)
Emergency pallidotomy in a patient with chorea paralytica in primary hypoparathyroidism

K. Garg, R. Rajan, M. Singh (New Delhi, India)
Empower-PD: “An Exploratory Investigation of Accelerometer Data on Parkinson’s Patients’ Motor Symptoms and the Correlation with Quality of Life.”

M. Hansen, B. Sørensen, T. Thomsen, N. Karottki (Copenhagen, Denmark)
EMPOWER-PD: Testing and evaluation of an 8-week co-created Self-management program tailored People with Parkinson`s disease and their caregivers in an interventional follow-up study

T. Thomsen, S. Skovbølling, M. Brønden, M. Møller, J. Frederiksen, B. Biering-Sørensen (Roskilde, Denmark)
Engage, Educate and Empower: Parkinson’s Research Advocates from the Black and African American Community

R. Mills-Joseph, K. Gamble, T. Best, K. Williams, L. Wilson, D. Coley, B. Coley, M. Fitts, R. Huckabee, A. Huckabee, E. Lewis, L. Seghetti, C. Branson, H. Shah, A. Kumeh, C. Gallagher, C. Evers, E. Stevens (Columbus, USA)
Engagement of the Black and African American Community in Parkinson’s Genetic Research

E. Stevens, A. Kumeh, S. Sauveur, D. Oguoma-Richards, R. Huckabee, A. Huckabee, D. Coley, B. Coley, M. Fitts, E. Lewis, L. Seghetti, T. Best, K. Gamble, K. Williams, L. Wilson, R. Joseph, H. Shah, C. Gallagher, C. Evers, J. Beck, A. Naito, C. Branson (New York, USA)
Enhancing iRBD diagnosis through 2D video analysis: a machine learning approach

M. Abdelfattah, O. Sum-Ping, J. Galati, S. Marwaha, A. Alahi, E. During (Lausanne, Switzerland)
Enhancing Real-Life Gait Performance in Persons with Parkinson Disease through the Music-Based BeatWalk Application

A. Bourdon, V. Cochen, B. Bardy, L. Damm (France, France)
Enlarged Perivascular Spaces in the Temporal Lobe as a Predictor for Incident Dementia in Parkinson’s Disease

HK. Na, Y. Sun, JH. Lee, CW. Park, YH. Sohn, CH. Lyoo, PH. Lee (Seoul, Republic of Korea)
ENLITE PD – A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson’s Disease

A. Videnovic, E. Macklin, C. Coffey, M. Cudkowicz, HJ. Cho, J. Ohayon, A. Amara, K. Marder, P. Zee, C. Desir, H. Ernst, E. Steinhart, M. Costigan, A. Gudjonsdottir, D. Ecklund, M. Chase, S. Criswel, D. Charles, J. Coleman, A. Espay, A. Hung, S. Kadimi, A. Killoran, L. Luo, R. Malkani, J. Margolesky, J. Marsella, C. Maurer, D. Mihaila, P. Moretti, A. Park, P. Phielipp, H. Sarva, B. Shah, H. Shill, A. Siderowf, V. Suski, J. Tate, W. Tse, K. Wyant, L. Zhang, E. Klerman (Boston, USA)
Enviromental Risk Factors for Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network

N. Obianozie, O. Ojo, 0. Agabi, N. Okubadejo, N. Research Network (Abuja, Nigeria)
Environmental Factors are Associated with Disease Severity of LRRK2 Related Parkinson’s Disease and Idiopathic Parkinson’s Disease: a Longitudinal Study

T. Lüth, A. Caliebe, C. Gabbert, S. Koch, B-H. Laabs, IR. König, C. Klein, J. Trinh (Lübeck, Germany)
Environmental risk factors and demographic of patients with Progressive Supranuclear Palsy from Argentina

F. Rellan, B. Couto, F. Gonzalez Del-Boca, M. Paez Magio, C. Villa, E. Franchello, G. Alvarado, G. Mizraji, D. Nadile, C. Tanner, O. Gershanik, C. Marras (Buenos Aires, Argentina)
Epidemiology of Huntington’s Disease in Latin America: A Systematic Review and Meta-analysis.

A. Medina Escobar, T. Pringsheim, S. Gautreau, J. Rivera-Duarte, G. Amorelli, M. Cornejo-Olivas, M. Rossi (Moncton, Canada)
Episodes of Hypoglycemia in Patients with Parkinson’s Disease – Results of Two-Week Continuous Glucose Monitoring

T. Chmiela, A. Gorzkowska (Katowice, Poland)
Essential Tremor: The Relationship Between Hand Dominance and Tremor Severity by MVPA

AS. Torres-Torres, JR. Dalenberg, AMM. Van-Der Stouwe, MAJ. Tijssen (Groningen, Netherlands)
Essential3: An Innovative Multi-Study Phase 3 Program to Evaluate the Efficacy and Safety of Ulixacaltamide

R. Able, M. Giroux, J. Zhao, H. Jacotin, M. Sniecinski, A. Samaroo, A. La Croix, A. Wyant, C. Santos, M. Souza (Boston, USA)
Establishing α-Synuclein Seeding Activity in Saliva as a Noninvasive Diagnostic Biomarker for Parkinson’s Disease

Z. Wang, S. Gunzler, S. Chen, Q. Kong (Cleveland, USA)
Estimating the Proportion of Parkinson’s Disease Clinical Trial Subjects Who Showed No Measurable MDS-UPDRS Motor Score Progression Over 1 Year

M. Pang, J. Edgerton, L. Zhu, S. Belachew, D. Taylor, C. Kanzler, M. Yang, F. Nahab, C. Shen (Cambridge, USA)
Ethnic and Gender Disparities in Access to Deep Brain Stimulation: A Qualitative Exploration

S. Corrick, J. Miyasaki, K. Yen, B. Salami, P. Torabi, G. Dimapilis, F. Ba (Edmonton, Canada)
Ethnic Diversity and Symptomatology in Parkinson’s Disease with a Focus on Falls and Vertical Gaze Palsy

D. Trivedi, C. Edwards, KC. Dey, E. Camboe, T. Haque, A. Joseph, J. Kahan, D. Gallagher, T. Boyle, C. Budu, B. Huxford, C. Simonet, S. Ganesh, A. Lee, C. Marshall, A. Noyce, A. Zirra (London, United Kingdom)
Evaluating Adaptive Devices to Assist Eating in Essential Tremor Patients: A Comparative Analysis

K. Adabi, W. Ondo (Houston, USA)
Evaluating Clinical Practices of General Neurologists and Movement Disorder Specialists Based on 2020 AAN Parkinson Disease Quality Metrics

C. Marshall, P. Vaswani (Philadelphia, USA)
Evaluating Cognitive Status in Parkinson’s Disease Using a Software-based Eye-Tracking Platform: Preliminary Results of the PALOMA Clinical Trial

M. Tosin, C. Goetz, R. Armstrong, C. Januario, B. Balint, P. Mir (Chicago, USA)
Evaluating Fall Risk in People with Parkinson’s Disease Using a Novel Comprehensive Posturography Assessment

P. Carlson-Kuhta, C. Silva-Batista, A. Ragothaman, M. Abdollahi, J. Ellison, G. Harker, G. Marchesi, A. de Luca, V. Squeri, F. Horak, M. Mancini (Portland, USA)
Evaluating Pharmacological Interventions for Friedreich Ataxia: A Network Meta-Analysis of Randomised Trials

T. Dave, V. Kumar, R. Raj, MA. Shamim, V. Suresh, K. Patel, M. Hassan, A. Bhonsale, DVV. Krishna, B. Dhakal, A. Ambulinambi, D. Dey (Chernivtsi, Ukraine)
Evaluating the association between cognitive impairment and striatal VMAT2 binding using [18F]AV-133 PET in Parkinson’s disease

K. Hwang, J. Langley (Long Beach, USA)
Evaluating the Effect of Myofascial Release on Parkinson’s Related Tremor

S. Phelps (Cardiff, United Kingdom)
Evaluating the Impact of the Pain Self-Management Program in PD

A. Zawar (Lynnwood, USA)
Evaluation of Effectiveness of Medical Nutrition Therapy Services for Individuals with Parkinson’s Disease: A Quality Improvement Initiative

S. Mandali, K. Lyons, K. Lee, K. Au, A. Lee, R. Pahwa (KansasCity, USA)
Evaluation of Functional Impairment and Treatment Satisfaction in Patients With Essential Tremor: a Cross-Sectional Study of Physicians Using Real-World Data

T. Saifee, L. Barbato, J. Lin, A. Sillah, M. Baladi, S. Thomas, A. Gillespie, L. Harrison, S. Shah (London, United Kingdom)
Evaluation of Glymphatic System Function in Parkinson’s disease patients using Diffusion MRI

M. Seki, R. Ueda, R. Okochi, Y. Sakai, T. Nukariya, S. Okusa, T. Tezuka, Y. Nihei, J. Nakahara (Tokyo, Japan)
Evaluation of Infusion Site Adverse Events With Foslevodopa/Foscarbidopa in a 12-Week, Randomized Study

S. Isaacson, R. Kirsner, O. Vaou, R. Pahwa, R. Hauser, L. Bergmann, R. Gupta, M. Shah, S. Varughese, T. Kimber (Boca Raton, USA)
Evaluation of neuroprotective effects of doxycycline in a primate model of PD

L. Pedrosa, L. Leal, J. Muniz, E. Del-Bel, B. Gomes, L. Krejcová (Belém, Brazil)
Evaluation of Neurotransmitter and Co-transmitter Expression in the Aging Human Locus Coeruleus: Relevance to Neurodegenerative Disorders.

A. Bhattacharya, A. Mahadevan, R. Manjithaya, Y. Tc, P. Alladi (Bengaluru, India)
Evaluation of the results of neuromodulation of the Subthalamic Nucleus (STN) in patients with Parkinson’s Disease (PD) depending on the anesthesia used during stereotactic electrode implantation.

V. Bayarchyk, A. Buniak (Minsk, Belarus)
Evaluation of theta burst transcranial ultrasound stimulation on motor cortex in Parkinson’s denovo patients.

T. Grippe, Y. Shamli-Oghli, G. Darmani, Y. Lin, T. Arora, C. Sarica, N. Raies, JF. Nankoo, F. Cardoso, R. Chen (Toronto, Canada)
Evaluation of unsteadiness in patients with dystonia

K. Pillai, P. Chavan, K. Mansukhani, V. Patil, A. Sharma, H. Halani, V. Pardasani, S. Khadilkar, J. Lalkaka, R. Singh, N. Barucha (Mumbai, India)
Evidence of basal ganglia involvement in mask-induced inhibition

P. Daye, A. Sangaré, B. Gaymard, P. Pouget (Ottignies-Louvain-la-Neuve, Belgium)
Evoked Resonant Neural Activity Automates Field Shaping of Subthalamic Nucleus-Deep Brain Stimulation in Parkinson’s Disease

K. Nagao, T. Perera, M. Petoe, W-L. Lee, S. Xu, K. Lawson, A. Moorhead, H. Mcdermott, W. Thevathasan (East Melbourne, Australia)
Examination of how DaTscan Impacts Diagnosis in Parkinsonian Patients with and without Dopamine Receptor Blocking Agent Exposure

R. Lopez-Castellanos, S. Factor, R. Blakes (Atlanta, USA)
Examining and contextualizing free-living heart rate using multiple wearable sensors: a potential approach for assessing autonomic dysfunction in Parkinson’s disease?

FE. Godkin, K. van Ooteghem, K. Ehgoetz Martens, K. Weber, B. Cornish, K. Beyer, D. Olszewska, C. Fearon, A. Lang, R. Swartz, M. Masellis, B. Tan, J. Tung, A. Roberts, W. Mcilroy (Waterloo, Canada)
Examining the Effects of Deep Brain Stimulation on Speech in Parkinson’s Disease

H. Kabakoff, A. Mogilner, M. Pourfar, A. Flinker (Brooklyn, USA)
Exercise for Parkinson’s: Building a Person-centered Resource through Partnership

R. Dolhun, L. Quinn (New York, USA)
Exercise Mitigates DNA Methylation Changes at cg17274742 Associated with the Circadian Gene Variant PER2 rs2304672: A Biobank Analysis

YC. Chen, SL. Wu, YP. Liaw (Changhua, Taiwan)
Exercise-induced angiogenesis and midbrain neuroprotection in a mouse model of experimental PD

T. Rodriguez, R. Smeyne, M. Smeyne (Philadelphia, USA)
Exidavnemab offers opportunities as a potential disease modifying therapy in several synucleinopathies

F. Eriksson, J. Fälting, E. Nordström, L. Söderberg, M. Johannesson, O. Zachrisson, P. Appelkvist, C. Möller, G. Osswald, M. Björklund, T. Odergren, E. Boström, E. Button, D. Sunnemark (Stockholm, Sweden)
Expanding Diversity of Parkinson’s Disease and Related Disorders Genetic Data: from the Global Parkinson’s Genetics Program

G. Parkinson'S_genetics_program (gp2) (Bethesda, USA)
Expanding Phenotype of LRRK2 G2019S Mutation: Case Description of Two Sisters Showing Peculiar Phenomenological Traits

S. Cartella, S. Neri, G. Foti, G. Cartella (Reggio Calabria, Italy)
Expanding the concept of “occupational dystonia”: data from the Italian Dystonia Registry

V. Velucci, L. Di Lorenzo, R. Erro, I. Di Somma, M. Esposito, A. Trinchillo, D. Belvisi, G. Fabbrini, G. Ferrazzano, S. Idrissi, R. Pellicciari, L. Avanzino, F. Di Biasio, C. Terranova, V. Rizzo, A. Castagna, M. Ramella, F. Bono, M. Barillari, M. Altavista, L. Polidori, C. Lettieri, C. Artusi, C. Scaglione, P. Barbero, L. Magistrelli, M. Petracca, R. Ceravolo, G. Cossu, T. Schirinzi, G. Squintani, A. Gigante, A. Muroni, T. Ercoli, M. Mascia, A. Berardelli, G. Defazio (Bari, Italy)
Expanding the Neurogenetic Spectrum: A Case of DEPDC5 Mutation Presenting with Unilateral Tremor and Cognitive Decline

B. Center, Z. Cheng (Maywood, USA)
Expanding the PD GENEration Study to increase clinical genetic testing and counseling using whole genome sequencing among diverse Parkinson’s disease (PD) populations

K. Ghosh Galvelis, A. Naito, M. Dini, S. Rao, R. Deleon, A. Coral-Zambrano, T. Foroud, P. Hodges, L. Heathers, J. Verbrugge, L. Cook, J. Schulze, M. Totten, A. Hall, K. Marder, I. Mata, N. Mencacci, T. Simuni, M. Nance, M. Schwarzschild, A. Wills, S. Lawrence, P. Ponger, J. Beck, R. Alcalay (New York, USA)
Expanding the Phenotype of a Novel Mutation in ELOVL4 and the Differential Diagnosis of the Hot Cross Bun Sign

G. Olmedo Saura, C. Pont Sunyer, I. Navalpotro Gomez, S. Bernal Noguera, B. Rodriguez Santiago, D. Guisado-Alonso, J. Pagonabarraga, C. García Sánchez, J. Kulisevsky, J. Perez Perez (Barcelona, Spain)
Expanding the phenotypic spectrum of movement disorders in 22q11.2 deletion syndrome

N. Reyes, T. Cortez-Grippe, M. Callister, T. Heung, A. Bassett, A. Lang (Toronto, Canada)
Expanding the Spectrum of Autosomal Recessive Genes Responsible for Parkinson’s Disease in the Chinese Population

Y. Zhao, H. Pan, J. Guo, Z. Liu, B. Tang (Changsha, China)
Experiences of a personalised intervention to support self-management in PwP – PD-Care: Live Well with Parkinson’s

T. Rookes, K. Kantilal, K. Walters, N. Kime, A. Kassavou, M. Younossi, WN. Tsang, P. Schartau, B. Gardner, N. Davies, A. Schrag (London, United Kingdom)
Experiencing Life with Tourette Syndrome: The Invisible Effects of Tics

J. Martindale, J. Carson, K. Reilly, K. Pring, L. Chapman, J. Salsman, S. Daniel, S. Rapp, R. Strowd, E. Storch, J. Mink (Winston Salem, USA)
Exploratory Cross-Sectional Analysis of Lifestyle and Parkinson’s Disease Symptomatology

O. Di Martino, N. Meier, S. Shafer, B. Stewart-Burger (Irvine, USA)
Explore cellular heterogeneities of orbitofrontal cortex in multiple system atrophy using spatial transcriptomics

SY. Cheng, CL. Hsu, WH. Yu, KP. Chang, MC. Kuo (Taipei, Taiwan)
Exploring Correlations between Mutant Huntingtin, NfL, and MRI in Huntington’s Disease: A Multimodal Analysis

J. Pérez, S. Horta, G. Saura, A. Barba, A. Davi, A. Vázquez, E. Rivas, A. Campolongo, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)
Exploring feasibility and efficacy of a ballet-based intervention in advanced Parkinson’s disease.

A. Podlewska, L. Batzu, V. Leta, J. Staunton, P. Tall, M. Recaman, A. Rizos, F. Derbyshire-Fox, A. Hartley, I. Bakolis, C. Pariante, T. Woods, K. Ray Chaudhuri (London, United Kingdom)
Exploring MAPT Haplotypes in Parkinson’s Disease in a Diverse Cohort: Insights from the Global Parkinson’s Genetics Program

P. Reyes-Pérez, J. Hor, A. Sanyaolu, T. Toh, K. Senkevich, H. Leonard, K. Brolin (Querétaro, Mexico)
Exploring Non-Invasive Wearable Devices in Home Settings for Assessment and Treatment of the Duration of ON and OFF State and Freezing of Gait in Parkinson’s Disease: A Case Study.

V. Azoidou, A. Noyce, C. Simonet, A. Mackett (London, United Kingdom)
Exploring Quantitative Susceptibility Mapping in Wilson’s Disease- A Prospective Cohort Study

A. Aliyar, D. Radhakrishnan, A. Garg, A. Srivastava, R. Rajan, A. Pandit, A. Das, A. Agarwal (Delhi, India)
Exploring Retrospectively the Predisposing Factors of Sleep Disorders in Parkinson’s Disease.

SF. Arechavala Lopez, I. Fuentes Calvo, AJ. Hernández-Medrano, A. Cervantes-Arriaga, M. Rodríguez-Violante (CDMX, Mexico)
Exploring Supervised and Real-World Mobility in People with Parkinson’s Disease with and without Nocturnal Hypokinesia

E. Bianchini, D. Rinaldi, S. Galli, M. Alborghetti, L. de Carolis, P. Petit, P. Pacilio, T. Milane, C. Hansen, FE. Pontieri, N. Vuillerme (Rome, Italy)
Exploring the Feasibility of Telerehabilitation for Balance Deficits in People with PD; the TelePD Trial

L. King, C. Silva-Batista, J. Wilhelm, K. Scanlan, M. Stojak, P. Carlson-Kuhta, W. Liu, F. Horak, M. Mancini (Portland, USA)
Exploring the Impact of Mechanoacoustic Vibration Therapy on Mobility, Bone Density, and Postural Stability in Perimenopause Women with Huntington’s disease

S. Devi, R. Chauhan (Narsan, India)
Exploring the Influence of Gastrointestinal Symptoms on Non-Motor Fluctuations in Parkinson’s Disease: Insights from the ReMePark-2, a Mexican Cohort

A. Cervantes-Arriaga, AJ. Hernández Medrano, AL. Guerra-Anzaldo, A. Domínguez-García, DP. Romero-Terán, G. Rivera-Monroy, KI. Sánchez-Ramírez, MF. Medina-Pérez, M. Rodríguez-Violante, R. Baños-Betancourt, A. Abundes-Corona, SF. Arechavala Lopez, WF. Moguel-Cardín ()
Exploring the Influence of Sleep Disorders on Speech Intensity in Individual’s with Parkinson’s Disease

A. Senthinathan, K. Bean (Buffalo, USA)
Exploring the neural correlates of impulsivity and impulsive compulsive behaviors in Parkinson’s disease

E. Ubeda Matzilevich, B. Swinnen, L. Ricciardi, S. Little (San Francisco, USA)
Exploring the Neuroprotective Effects of Diurnal Light Exposure in Early-Stage Parkinson’s Disease: A Longitudinal, Multi-Sensory Intervention Study

S. Putri, R. Fajar, E. Syafruddin (Gresik, Indonesia)
Exploring the Neuroprotective Potential of Mushroom Extracts in Parkinson’s Disease In-Vitro Models

FAZ. Dustov, SEO. Seo (Tashkent, Uzbekistan)
Exploring the non-invasive epigenetic screening test for hereditary dystonia DYT-KMT2B

N. Sugeno, S. Kumada, H. Kashii, J. Ikezawa, T. Kawarai, T. Nakamura, S. Ishiyama, K. Sato, S. Yoshida, H. Sekiguchi, K. Hamanaka, S. Miyatake, N. Miyake, N. Matsumoto, H. Akagawa, K. Kosaki, H. Yoshihashi, T. Hasegawa, M. Aoki (Sendai, Japan)
Exploring the Prevalence of Subjective Cognitive Decline and Mild Cognitive Impairment in Participants of the Luxembourg Healthy Ageing Study

S. Jónsdóttir, C. Pauly, V. Schröder, O. Tsurkalenko, T. Marques, C. Horlings, A. Garrido, C. Vega, S. Schade, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, D. Mcintyre, K. Seppi, M. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, B. Mollenhauer, R. Krüger (Heisdorf, Luxembourg)
Exploring the Root of Cognitive Decline in People Living with Parkinson’s Disease: An Analysis of MoCA Scores, Neuropsychiatric Symptoms, and Patient-Reported Outcomes

K. Sánchez-Ramírez, S. Arechavala-Lopez, D. Romero-Terán, A. Hernández-Medrano, M. Medina-Pérez, A. Cervantes-Arriaga, M. Rodríguez-Violante (CULIACAN, Mexico)
Exploring the Therapeutic Potential of Microglial Modulation in Parkinson’s Disease: A Study on Structural Synaptic Plasticity

F. Fares Taie, I. Taravini, L. Rela (Buenos Aires, Argentina)
Exploring the Therapeutic Target for Lewy Body Disease using gba1 Knock-out Medaka

E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, H. Yamakado, R. Takahashi (kyoto, Japan)
Exploring Vestibulopathy in PD: Distinguishing PD from Age-related Presbyvestibulopathy via Dynamic Gait and Balance Assessment

G. Carli, D. Mccaslin, T. Brown, S. David, J. Barr, R. Vangel, A. Luker, C. Pongmala, K. Kerber, N. Bohnen (Ann Arbor, USA)
Exploring youth with Tourette syndrome whose tics first manifested after age 12

C. Nilles, D. Martino, J. Fletcher, T. Pringsheim (Paris, France)
Extended long-term follow-up focused ultrasound subthalamotomy in Parkinson´s disease: five-year prospective experience

E. Natera-Villalba, T. Jiménez Castellanos, R. Rodríguez-Rojas, M. Del álamo, JA. Pineda-Pardo, C. Gasca-Salas, M. Matarazzo, JA. Obeso, R. Martínez-Fernández (Madrid, Spain)
Eye Blink Rate and Putamen DaTScan Covariation in Parkinson’s Disease

Q. Salardaine, V. Vasudevan, N. Villain, E. Biondetti, S. Lehéricy, M. Vidailhet, P. Pouget (Paris, France)
Eye movements and cognitive function

A. Ovchynnykova, Y. Trufanov, M. Trishchynska (Kyiv, Ukraine)